Trial
NCT00584779
An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis
Phase IVTERMINATEDSAFETYConfidence: HIGH
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Collaborators
—
Condition
PK Properties Of Gabapentin In Subjects With Impaired Renal Function
Intervention
Gabapentin
Why stopped
See detailed description for termination reason
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2021-02-02